清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Dual anti-platelet therapy for secondary prevention in intracranial atherosclerotic disease: a network meta-analysis

医学 冲程(发动机) 荟萃分析 优势比 抗血栓 内科学 置信区间 梅德林 血小板聚集抑制剂 纤溶剂 阿司匹林 机械工程 政治学 法学 工程类
作者
Giuseppe Reale,Aurelia Zauli,Giuseppe La Torre,Alice Mannocci,Michael V. Mazya,Marialuisa Zedde,Silvia Giovannini,M. De Marco,Chiara Iacovelli,Pietro Caliandro
出处
期刊:Therapeutic Advances in Neurological Disorders [SAGE Publishing]
卷期号:15 被引量:5
标识
DOI:10.1177/17562864221114716
摘要

Intracranial arterial stenosis (ICAS) is a non-marginal cause of stroke/transient ischemic attacks (TIAs) and is associated with high stroke recurrence rate. Some studies have investigated the best secondary prevention ranging from antithrombotic therapy to endovascular treatment (ET). However, no direct comparison between all the possible treatments is currently available especially between single and dual anti-platelet therapies (SAPT and DAPT).To establish whether DAPT is more effective than SAPT in preventing the recurrence of ICAS-related stroke, by means of a network meta-analysis (NMA).Systematic review and NMA in accordance to PRISMA guidelines.We performed a systematic review of trials investigating secondary prevention (SAPT or DAPT, anticoagulant treatment or ET) in patients with symptomatic ICAS available in MEDLINE, Scopus and Web of Science from January 1989 to May 2021. We defined our primary efficacy outcome as the recurrence of ischemic stroke/TIA. We analysed the extracted data with Bayesian NMA approach.We identified 815 studies and included 5 trials in the NMA. Sequence generation was adequate in all the selected studies while the allocation concealment method was described in one study. All the included studies reported the pre-specified primary outcomes, and outcome assessment was blinded in all the studies. We used the fixed-effect approach as the heterogeneity was not significant (p > 0.1) according to the Cochran's Q statistic. DAPT was superior to SAPT and DAPT + ET in preventing stroke/TIA recurrence [respectively, odds ratio (OR), 0.59; confidence interval (CI), 0.39-0.9; and OR, 0.49, CI, 0.26-0.88], while no difference was found between DAPT and oral anticoagulant therapy (OAC). DAPT was safer than OAC (OR, 0.48; CI, 0.26-0.89) and DAPT + ET (OR, 0.50; CI, 0.35-0.71), while no difference was found between DAPT and SAPT.DAPT is more effective than SAPT for secondary stroke prevention in patients with symptomatic ICAS, without increasing the risk of haemorrhage.Prospero/CRD42019140033.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
蓝意完成签到,获得积分0
刚刚
李健的应助被TingtingGZ采纳,获得10
5秒前
英姑的应助被TingtingGZ采纳,获得10
5秒前
科研通AI6.2的应助被TingtingGZ采纳,获得10
5秒前
上官若男的应助被TingtingGZ采纳,获得10
6秒前
Hello的应助被TingtingGZ采纳,获得10
6秒前
科研通AI65的应助被TingtingGZ采纳,获得10
6秒前
万能图书馆的应助被TingtingGZ采纳,获得10
6秒前
molihuakai的应助被TingtingGZ采纳,获得10
6秒前
李健的小迷弟的应助被TingtingGZ采纳,获得30
6秒前
GingerF的应助被TingtingGZ采纳,获得200
6秒前
13秒前
快乐的稚晴完成签到,获得积分10
22秒前
紫熊完成签到,获得积分10
28秒前
热情菲鹰完成签到,获得积分10
29秒前
Luoyan完成签到,获得积分10
41秒前
43秒前
优雅的傲柏完成签到,获得积分10
49秒前
54秒前
我想进步完成签到,获得积分10
56秒前
坚强含烟完成签到,获得积分10
58秒前
龙龙发布了新的文献求助10
1分钟前
1分钟前
1分钟前
随心所欲完成签到 ,获得积分10
1分钟前
Ava的应助被龙龙采纳,获得10
1分钟前
怕孤单的雪瑶完成签到,获得积分10
1分钟前
陈荆洲完成签到,获得积分10
1分钟前
1分钟前
从容的绿蝶完成签到,获得积分10
1分钟前
如意夏寒完成签到,获得积分10
1分钟前
1分钟前
2分钟前
老戎完成签到 ,获得积分10
2分钟前
2分钟前
petrichor发布了新的文献求助10
2分钟前
孤独的芹菜完成签到,获得积分10
2分钟前
2分钟前
龙龙发布了新的文献求助10
2分钟前
腼腆的雪珊完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173194
求助须知:如何正确求助?哪些是违规求助? 9565558
关于积分的说明 21780476
捐赠科研通 7767279
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555697
邀请新用户注册赠送积分活动 2476682